NIH Image Gallery from Bethesda, Maryland, USA, Public domain, via Wikimedia Commons

NIH Image Gallery from Bethesda, Maryland, USA, Public domain, via Wikimedia Commons


Anthony S. Fauci, MD, who was instrumental in leading the country through the COVID-19 pandemic, announced today through a statement from the National Institutes of Health (NIH) that he is stepping down from the positions of Director of the National Institute of Allergy and Infections Diseases (NIAID) and Chief of the NIAID Laboratory of Immunoregulation, as well as the position of Chief Medical Advisor to President Joe Biden, effective in December of this year to pursue the next chapter of his career. 

Fauci stated in the release:

"It has been the honor of a lifetime to have led the NIAID, an extraordinary institution, for so many years and through so many scientific and public health challenges. I am very proud of our many accomplishments. I have worked with — and learned from — countless talented and dedicated people in my own laboratory, at NIAID, at NIH and beyond. To them I express my abiding respect and gratitude.

"Over the past 38 years as NIAID Director, I have had the enormous privilege of serving under and advising seven Presidents of the United States, beginning with President Ronald Reagan, on newly emerging and re-emerging infectious disease threats including HIV/AIDS, West Nile virus, the anthrax attacks, pandemic influenza, various bird influenza threats, Ebola and Zika, among others, and, of course, most recently the COVID-19 pandemic. I am particularly proud to have served as the Chief Medical Advisor to President Joe Biden since the very first day of his administration.

"While I am moving on from my current positions, I am not retiring. After more than 50 years of government service, I plan to pursue the next phase of my career while I still have so much energy and passion for my field. I want to use what I have learned as NIAID Director to continue to advance science and public health and to inspire and mentor the next generation of scientific leaders as they help prepare the world to face future infectious disease threats.

"Over the coming months, I will continue to put my full effort, passion and commitment into my current responsibilities, as well as help prepare the Institute for a leadership transition. NIH is served by some of the most talented scientists in the world, and I have no doubt that I am leaving this work in very capable hands.

"Thanks to the power of science and investments in research and innovation, the world has been able to fight deadly diseases and help save lives around the globe. I am proud to have been part of this important work and look forward to helping to continue to do so in the future."

For more information: www.nih.gov

Related Long-COVID Content: 

MRI Sheds Light on COVID Vaccine-Associated Heart Muscle Injury 

What We Know About Cardiac Long-COVID Two Years Into the Pandemic  

VIDEO: Long-term Cardiac Impacts of COVID-19 Two Years Into The Pandemic — Interview with Aaron Baggish, M.D. 

VIDEO: Long-COVID Presentations in Cardiology at Beaumont Hospital — Interview with Justin Trivax, M.D. 

VIDEO: Cardiac Presentations in COVID Long-haulers at Cedars-Sinai Hospital — Interview with Siddharth Singh, M.D. 

Find more COVID news and videos 

Related COVID Content: 

COVID-19 Fallout May Lead to More Cancer Deaths 

Kawasaki-like Inflammatory Disease Affects Children With COVID-19 

FDA Adds Myocarditis Warning to COVID mRNA Vaccine Clinician Fact Sheets 

CMS Now Requires COVID-19 Vaccinations for Healthcare Workers by January 4 

Cardiac MRI of Myocarditis After COVID-19 Vaccination in Adolescents 

Small Number of Patients Have Myocarditis-like Illness After COVID-19 Vaccination 

Overview of Myocarditis Cases Caused by the COVID-19 Vaccine 

Case Study Describes One of the First U.S. Cases of MIS-C 

NIH-funded Project Wants to Identify Children at Risk for MIS-C From COVID-19 


Related Content

Feature | Radiology Business | By William T. Thorwarth Jr., MD, FACR

As we witness a mounting backlash against prior authorization in healthcare, we must explore more effective alternatives ...

Time May 02, 2024
arrow
News | Breast Imaging

May 1, 2024 — Hologic, Inc., a global leader in women’s health, today announced that it signed a definitive agreement to ...

Time May 01, 2024
arrow
News | Breast Imaging

May 1, 2024 — After the issuance of updated breast screening recommendations by the U.S. Preventive Services Task Force ...

Time May 01, 2024
arrow
Feature | Information Technology | By Melinda Taschetta-Millane

The Healthcare Information and Management Systems Society (HIMSS) Global Health Conference and Exhibition brought ...

Time May 01, 2024
arrow
News | FDA

April 30, 2024 — International medical imaging IT and Cybersecurity company Sectra’s digital pathology solution together ...

Time April 30, 2024
arrow
Feature | Breast Imaging | By Christine Book

From implementing artificial intelligence effectively, advocating for radiologists, and working tirelessly to expand ...

Time April 29, 2024
arrow
News | Information Technology

April 25, 2024 — NewVue Inc., a leader in innovative cloud-native radiology workflow solutions, announced a strategic ...

Time April 25, 2024
arrow
News | Radiation Dose Management

April 25, 2024 — BIOTRONIK, a leading global medical technology company specializing in innovative cardiovascular and ...

Time April 25, 2024
arrow
News | Artificial Intelligence

April 19, 2024 — Large language model GPT-4 matched the performance of radiologists in detecting errors in radiology ...

Time April 22, 2024
arrow
News | Mammography

April 16, 2024 — The Radiological Society of North America (RSNA) and GE HealthCare announced their collaboration to ...

Time April 16, 2024
arrow
Subscribe Now